Search bioRxiv⌕ Search

Biology subjects

Mimar, S.

Publications and source records attributed to Mimar, S..

2 recordsLinked to original sources

FUSION: A web-based application for in-depth exploration of multi-omics data with brightfield histology

Spatial -OMICS technologies facilitate the interrogation of molecular profiles in the context of the underlying histopathology and tissue microenvironment. Paired analysis of histopathology and molecular data can provide pathologists with otherwise unobtainable insights into biological mechanisms. To connect the disparate molecular and histopathologic features into a single workspace, we developed FUSION (Functional Unit State IdentificatiON in WSIs [Whole Slide Images]), a web-based tool that provides users with a broad array of visualization and analytical tools including deep learning-based algorithms for in-depth interrogation of spatial -OMICS datasets and their associated high-resolution histology images. FUSION enables end-to-end analysis of functional tissue units (FTUs), automatically aggregating underlying molecular data to provide a histopathology-based medium for analyzing healthy and altered cell states and driving new discoveries using "pathomic" features. We demonstrate FUSION using 10x Visium spatial transcriptomics (ST) data from both formalin-fixed paraffin embedded (FFPE) and frozen prepared datasets consisting of healthy and diseased tissue. Through several use-cases, we demonstrate how users can identify spatial linkages between quantitative pathomics, qualitative image characteristics, and spatial --omics

pathology↗

ComPRePS: An Automated Cloud-based Image Analysis tool to democratize AI in Digital Pathology

Digital pathology using whole slide imaging (WSI) and artificial intelligence (AI) has the potential to transform diagnostic workflows, but adoption remains limited by technical complexity and scalability. We developed the Computational Renal Pathology Suite (ComPRePS), a scalable cloud-based platform that automates WSI ingestion, compartmental segmentation, feature extraction, and AI-assisted interpretation through an integrated high-performance architecture. ComPRePS was evaluated in two use cases. First, using 213 procurement biopsies, we compared conventional assessments with automated AI analyses and a hybrid AI-assisted expert workflow. ComPRePS AI-assisted methods achieved higher precision and significantly improved interobserver agreement for key lesions, including global glomerulosclerosis, interstitial fibrosis and tubular atrophy, and arterial intimal thickening. Second, ComPRePS enabled high-throughput quantitative profiling of glomerular and tubular features across minimal change disease, diabetic nephropathy, and amyloid nephropathy revealing disease-specific phenotypic patterns inaccessible to manual evaluation. Overall, ComPRePS improves reproducibility, interpretability, and objectivity in renal pathology, bridging computation with clinical practice.

pathology↗